Editor’s summary Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne virus now lacking a vaccine or therapeutics. Here, Wu et al. aimed to address this gap by isolating and characterizing nanobodies against this virus. A subset of nanobodies isolated from an alpaca after a series of immunizations exhibited potent neutralization of SFTSV, and a subset conferred protection against disease in SFTSV-infected mice.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Junyi
Contact Junyi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack